Unveiling the role of SOS genes in E. coli survival during antibiotic treatment

FHS
June 20, 2024
5:42 pm

When E. coli detects damage to its genetic material, it sends out an SOS signal that alters activity inside the cells.

Opinion | Neffy Is About to Hit Shelves: Considerations for Prescribing

Rubin is a pediatrician specializing in allergy and immunology. The FDA recently approved the first needle-free epinephrine product (neffy), an alternative to injectable epinephrine (EpiPen)

September 4, 2024

Advancing quality integrated health services through relational community engagement

A new report, entitled “Relationality in community engagement: its role in humanizing healthcare and achieving quality integrated health Services” has been developed in collaboration with

December 22, 2024

AbbVie announces RINVOQ availability for paediatric arthritis

RINVOQ is indicated for children with pJIA and PsA who have shown an inadequate response or intolerance to one or more TNF blockers. Credit: Copyright

June 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.